Neural Prostheses and Gait Performance: Model-Based Strategies

NCT ID: NCT00991406

Last Updated: 2019-08-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to find the optimal patterns of functional electrical stimulation (FES) of muscles in the lower legs that will improve walking ability in those who have had a stroke and at the same time ensure walking stability. FES involves applying small electric currents to the nerves, which cause the muscles to contract.

FES research projects vary from simple investigations of the therapeutic effects of exercise on muscle function and skin health, to more complex studies of functional movements such as standing or walking.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims to find the optimal patterns of functional electrical stimulation (FES) of muscles in the lower legs that will improve walking ability in those who have had a stroke and at the same time ensure walking stability will be achieved through an analytical approach comprised of computational models and gait simulations to objectively determine patient-specific patterns of muscle activation. The investigators will develop a computer simulation of the dynamics of hemiplegic gait characterized by unilateral plantarflexor weakness. Then, the investigators will relate the results of the computer model results to real data collected from subjects with known plantarflexor weakness to provide a theoretical basis for improving gait efficiency and stability with FES.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiplegia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1: FES

Case-control study: pre- and post-stimulation (FES).

Group Type EXPERIMENTAL

FES

Intervention Type DEVICE

Surface stimulation to contract the muscles in the lower extremity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FES

Surface stimulation to contract the muscles in the lower extremity

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

This study includes stroke survivors greater than 18 years of age, \>180 days from first clinical hemorrhagic or nonhemorrhagic stroke with:

* Unilateral hemiparesis with sufficient endurance and motor ability to ambulate \>30 feet continuously without an AFO requiring no more than 25% physical help
* Berg Balance Scale score \>23 without assistive devices
* Standing ankle dorsiflexion strength of \<4/5
* Foot-drop during ambulation with gait instability or inefficient gait defined as supervision need
* Possible use of physical assistance or assistive device (cane, walker)
* Evidence of foot-drop as seen by "dragging" or "catching" of affected toes during limb swing or circumducting affected limb
* Vaulting of the unaffected limb or hiking the affected hip to clear toes.
* Intact and electrically ex-citable lower motor neurons
* Ankle dorsiflexion to at least neutral while standing with electrical stimulation of common peroneal and tibial nerves without painful hypersensitivity to stimulation
* Adequate social support and stability
* Medically stable with intact skin in affected lower limb
* Willingness to comply during research procedures
* No systemic co-morbidities
* No history of potentially fatal cardiac arrhythmias i.e. ventricular tachycardia, supraventricular tachycardia and rapid ventricular response atrial fibrillation with hemodynamic instability
* No psychological problems or chemical dependency
* No acute medical complications such as depression or chronic anxiety requiring long term pharmacological therapy. Able-bodied controls must be of similar age, body mass and stature as those with hemiparesis and must be free of any medical and disabling orthopedic problems.


* Requires an ankle foot orthosis (AFO) to prevent knee flexion collapse in stance
* Excessive edema of affected extremity
* Absent sensation in affected limb
* History of potentially fatal cardiac arrhythmias such as ventricular tachycardia, supraventricular tachycardia, and rapid ventricular response, atrial fibrillation with hemodynamic instability
* Demand pacemakers or any implanted electronic systems
* Pregnancy
* Uncontrolled seizure disorder
* Ipsilateral lower limb lower motor neuron lesion
* Parkinson's disease
* Spinal cord injury
* Traumatic brain injury
* Multiple sclerosis
* Ankle plantar flexor contraction
* Severely impaired cognition and communication
* Painful hypersensitivity to neuromuscular stimulation of common peroneal nerve
* Knee hyperextension (genu recurvatum) that cannot be adequately corrected with peroneal nerve stimulation
* History of botulinum toxin to the lower extremity within the prior three months.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elizabeth C Hardin van den Bogert, PhD MS

Role: PRINCIPAL_INVESTIGATOR

Louis Stokes VA Medical Center, Cleveland, OH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B4668-R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.